What is a stock summary page? Click here for an overview.
Business Description
Cannapharmarx Inc
NAICS : 325412
SIC : 2834
ISIN : US13765D1090
Description
Cannapharmarx Inc is involved in the cannabis sector. The company negotiates, acquires, and develops various cannabis cultivation projects throughout Canada. Its three projects include the Hanover Project; the Great Northern Project, and the Acquisition of Sunniva Medical.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -1.42 | |||||
| Debt-to-Equity | -0.87 | |||||
| Debt-to-EBITDA | 3.76 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | -12.67 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EPS without NRI Growth Rate | 74.1 | |||||
| 3-Year FCF Growth Rate | 17 | |||||
| 3-Year Book Growth Rate | 44 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 14.83 | |||||
| 9-Day RSI | 29 | |||||
| 14-Day RSI | 34.98 | |||||
| 3-1 Month Momentum % | -50.62 | |||||
| 6-1 Month Momentum % | -53.49 | |||||
| 12-1 Month Momentum % | -72.97 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.07 | |||||
| Quick Ratio | 0.01 | |||||
| Days Inventory | 366.77 | |||||
| Days Sales Outstanding | 139.3 | |||||
| Days Payable | 2739.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -111.1 | |||||
| Shareholder Yield % | 71.51 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -234.62 | |||||
| Operating Margin % | -283.73 | |||||
| Net Margin % | 407.99 | |||||
| FCF Margin % | -835.5 | |||||
| ROE % | Neg. Equity | |||||
| ROA % | 13.35 | |||||
| ROIC % | -4.3 | |||||
| 3-Year ROIIC % | -111.61 | |||||
| ROC (Joel Greenblatt) % | 67.96 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | N/A |
N/A
|
N/A
| |||
| PE Ratio without NRI | 4.8 | |||||
| EV-to-EBIT | 4.6 | |||||
| EV-to-EBITDA | 4.61 | |||||
| EV-to-Revenue | 52.28 | |||||
| EV-to-FCF | -6.26 | |||||
| Earnings Yield (Greenblatt) % | 21.74 | |||||
| FCF Yield % | -88.81 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CPMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cannapharmarx Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.338 | ||
| EPS (TTM) ($) | - | ||
| Beta | -2189.02 | ||
| 3-Year Sharpe Ratio | 0.44 | ||
| 3-Year Sortino Ratio | 3 | ||
| Volatility % | 73.61 | ||
| 14-Day RSI | 34.98 | ||
| 14-Day ATR ($) | 0.000975 | ||
| 20-Day SMA ($) | 0.00489 | ||
| 12-1 Month Momentum % | -72.97 | ||
| 52-Week Range ($) | 0.0001 - 0.019 | ||
| Shares Outstanding (Mil) | 662.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cannapharmarx Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cannapharmarx Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cannapharmarx Inc Frequently Asked Questions
What is Cannapharmarx Inc(CPMD)'s stock price today?
The current price of CPMD is $0.00. The 52 week high of CPMD is $0.02 and 52 week low is $0.00.
When is next earnings date of Cannapharmarx Inc(CPMD)?
The next earnings date of Cannapharmarx Inc(CPMD) is 2025-04-24 Est..
Does Cannapharmarx Inc(CPMD) pay dividends? If so, how much?
Cannapharmarx Inc(CPMD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers